Emis Tc Generation Video

0 views
Skip to first unread message

Tamela Vandonsel

unread,
Aug 3, 2024, 5:27:18 PM8/3/24
to camroloran

In an EMIS, elements are put into gas form and positively electrically charged, then put through a magnetic field, which separates them by mass. Each isotope, having a different weight, travels through the field at a slightly different radius, allowing the different isotopes to be collected separately.

The technology was developed to fill a gap left by the 1998 closure of the Manhattan Project-era calutron facility at Y-12, which produced the now-dwindling U.S. stockpile of stable isotopes. EMIS development was funded by the Department of Energy Isotope Program to reduce U.S. dependence on foreign suppliers for rare, hard-to-produce stable isotopes. EMIS now can match or exceed the quality of isotopes produced at the calutrons.

While the original EMIS could separate isotopes of any element at decent resolution, the third-generation machine is optimized for separating elements at the heavier end of the periodic table, such as ytterbium, whose isotope Yb-176 is used in nuclear medicine and radiography.

EMIS features prominently in plans for the Stable Isotope Production and Research Center, or SIPRC, a new facility under construction now and expected to be operational by 2030. Its flexibility makes it a perfect complement to the gaseous centrifuge isotope separators, or GCIS, the lab is developing for multiple isotopes. Self-sufficient GCIS, which also will be used in SIPRC, can produce high volumes of isotopes at a low cost. But changing GCIS from one isotope to another is a process that can take years, whereas EMIS can switch from producing one isotope to another in a matter of weeks.

The lab also has established relationships with vendors to produce the ORNL-designed components for EMIS-3. Egle said parts for the technology come from as near as a small, family-owned electronics company in nearby Blount County, and as far away as an electromagnet facility in New Zealand. Vendors send fully integrated modules to ORNL to be assembled into the complete machine.

At our recent EMIS NUG Committee Meeting (Nov 29th) we were give a presentation of the future of our GP Clincial system; EMIS-X (try saying that quickly!). Simultaneously, EMIS were in London launching their proposal to the City. The text of their Press Staement is reproduced below.

EMIS Web is admittedly long overdue for a radical overhaul. The current GP systems no longer meet the needs to the rapidly developing healthcare environment, with multiple types of user working mainly on fixed infrastructure with a variety of providers operating across frequently changing sites with varied record requirements and a multiplicity of IT systems that don't talk to each other.

GP IT Futures, the new GP IT contract replacing GPSoC, to be introduced in a year or so, recognizes this and replaces the traditional single enclosed systems with an open, modular approach accessed on any device across the internet. It unlocks the market to providers to develop specific functional modules which are added to an approved 'catalogue' from which users can choose, defining core and optional elements. All the modules offered must be built to rigorous standards of full interoperability, the idea being that we have something, possibly an amalgam of different systems, which best meets our needs whilst fully integrating with others' solutions and sharing the same data. This is very ambitious of course but having a closed discrete architecture can no longer support the complexities of modern multi-dimensional, real-time healthcare. 200 new developers have been taken on by EMIS and we hope to see work happening reasonably swiftly compared to the pace of EMIS Web development in recent years. Of course, that necessarily means development of EMIS Web will be limited to smaller changes rather than big re-writes. The NUG UDR (User Driven Requirements) will still be intimately involved in the process under the requirements of GPSoC and your ideas remain important in driving this under our newly agreed process with EMIS (see blog below).

In order to avoid disrupting Business As Usual, EMIS-X will be gradually brought on stream; no 'big bang' with a steep learning curve. New EMIS-X functionality will be steadily introduced to EMIS Web and, being completely outside the present architecture, will present itself simply as an icon linking to the new module so users can move over at their own pace. First will be a new Appointments module , some time around the middle of 2019. This will be like any other browser-based booking system, for theatre tickets or hotels for instance, and will allow appointments of any sort to be booked from anywhere to any provider on any device. Because it will be deployed on the web, updates can be made more or less in real time, so goodbye to the process of writing and testing a complete module, rolling it out laboriously via the cumbersome patch domain system and then dealing equally slowly with bug fixes. It will end the problem of an addition in one part of the system breaking something in other parts.

EMIS has been positioning itself by acquiring a number of different companies and looks to offer sufficient expertise to provide a global healthcare system to compete with the best. This is vital if it is to survive as it seems likely the newly freed-up market will see many new entrants - and maybe the death of some existing players - and some of the new providers may well come from big players across the pond. Hospital IT has a long way to catch up with our own in primary care and huge and expensive systems are being procured now, which may well have a free GP bolt-on provided as a sweetner to the local health economy. Keeping a strong GP user voice in the choice of our new systems will be more important than ever as Federations, CCGs, STPs, CSUs will all jockey for position, the Trusts become ever more powerful and the stakes grow. We're not yet sure if the users will have a formal place in the process under GP IT Futures. Those who shout loudest or with the biggest financial clout could win and the end user, at the centre of the current GPSoC, could well be squeezed out of the decision making. EMIS have assured us they are strongly committed to our needs as customers and sees the NUG as a vital voice.

GPs and practices may need to ramp up presence at national level and if that happens the NUG will represent you. Your opinions need to be aired more loudly than ever and our channels - the NUG Facebook, Twitter, our email list, the conferences and surveys, local meetings, and EMIS's own channels - directly feed into the process. Our regular meetings with EMIS have become more fruitful in the past couple of years and we believe we do work with a listening organisation; we need to make the most of this.

We'll try to keep our members informed as things develop. Meanwhile if you have colleagues in local practices which are not yet members of the NUG, please do try to get them signed up and involved to make us even stronger. Exciting times are ahead!

EMIS-X, a new cloud-based solution that seamlessly links different healthcare teams and systems, is at the centre of a suite of innovations from the company, which serves healthcare professionals in over 10,000 UK organisations.

The next generation software will upgrade and extend EMIS Web, the clinical system used by 56% of GPs, to meet the current and future needs of customers and end users including patients, clinicians and the NHS.

EMIS Group CEO Andy Thorburn said: From the start, EMIS Group has led the way in interoperability and we have been working closely with clinicians and other customers during 2018 to develop EMIS-X. We believe it is the blueprint for the future of connected healthcare in the UK.

Emisshield and its Strategic Partners have years of experience working with your processes. We analyze your specific situation, provide a solution-based technology and apply it with professional precision. Our high emissivity materials are reducing downtime, minimizing coking, increasing production and reducing plants overall carbon footprint.

Emisshield solution based products are being put to the test every day, all around the world. Through the experience of our Emisshield Installers, Emisshield Products are able to be used in many different applications to help you increase the overall life of units and its components, production and the efficiency of your processes.

Emisshield products have been applied in over 130 glass plants world-wide. These applications are proving to be an incredible opportunity for glass manufactures to increase their energy efficiency, reduced downtime and increase their overall production. Our Products can be applied in the field by professional Emisshield Installers with minimal downtime.

Biomass boilers, waste incinerators, natural gas boilers, and their associated burners in the Power Generation Industry benefit in many ways from the application of Emisshield. In addition, Emisshield has a high abrasion resistance and has proven beneficial on many burner tips, swirlers and other parts of the plant.

Batch units like Crematories are subject to thermal shock, extended heat up times and increased fuel usage. Cremkote is a line of High Emissivity Materials designed by Emisshield specifically for maximizing your cremation units potential.

Emisshield can be used in a variety of multipurpose kilns including both intermittent and continuous kilns. Continuously fed kilns such as tunnel kilns has shown an improvement of efficiency on average of 8 -10% in furnaces where Emisshield Materials were applied, while coated intermittent kilns can improve its efficiency up to 15%.

Providing the highest quality technology to our customers is a what we strive for; as we have introduced high emissivity materials into our industries, we have developed partnerships with manufactures and producers who strive for that same quality. These partnerships provide customers with the opportunity to work with their suppliers and have certain parts of their furnace pre-coated in the factory.

c80f0f1006
Reply all
Reply to author
Forward
0 new messages